| Product Code: ETC7540040 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Clinical Trial Supply & Logistics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Clinical Trial Supply & Logistics Market Revenues & Volume, 2021 & 2031F |
3.3 India Clinical Trial Supply & Logistics Market - Industry Life Cycle |
3.4 India Clinical Trial Supply & Logistics Market - Porter's Five Forces |
3.5 India Clinical Trial Supply & Logistics Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 India Clinical Trial Supply & Logistics Market Revenues & Volume Share, By Phase, 2021 & 2031F |
3.7 India Clinical Trial Supply & Logistics Market Revenues & Volume Share, By Therapeutic, 2021 & 2031F |
3.8 India Clinical Trial Supply & Logistics Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 India Clinical Trial Supply & Logistics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for clinical trials in India due to a large patient pool and diverse population |
4.2.2 Growing investments in healthcare infrastructure and research development activities |
4.2.3 Favorable government initiatives and policies to boost clinical research and trials in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and compliance standards for conducting clinical trials |
4.3.2 Lack of skilled professionals and expertise in clinical trial supply chain management |
4.3.3 Limited awareness and understanding of clinical trial logistics among stakeholders |
5 India Clinical Trial Supply & Logistics Market Trends |
6 India Clinical Trial Supply & Logistics Market, By Types |
6.1 India Clinical Trial Supply & Logistics Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Logistics & Distribution, 2021- 2031F |
6.1.4 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Storage & Retention, 2021- 2031F |
6.1.5 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Packaging, Labeling, And Blinding, 2021- 2031F |
6.1.6 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Manufacturing, 2021- 2031F |
6.1.7 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Comparator Sourcing, 2021- 2031F |
6.1.8 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Other Services, 2021- 2031F |
6.2 India Clinical Trial Supply & Logistics Market, By Phase |
6.2.1 Overview and Analysis |
6.2.2 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Phase I, 2021- 2031F |
6.2.3 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Phase II, 2021- 2031F |
6.2.4 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Phase III, 2021- 2031F |
6.2.5 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.3 India Clinical Trial Supply & Logistics Market, By Therapeutic |
6.3.1 Overview and Analysis |
6.3.2 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.3 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.4 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Respiratory Diseases, 2021- 2031F |
6.3.5 India Clinical Trial Supply & Logistics Market Revenues & Volume, By CNS And Mental Disorders, 2021- 2031F |
6.3.6 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Clinical Trial Supply & Logistics Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Pharmaceuticals, 2021- 2031F |
6.4.3 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Biologicals, 2021- 2031F |
6.4.4 India Clinical Trial Supply & Logistics Market Revenues & Volume, By Medical Devices, 2021- 2031F |
7 India Clinical Trial Supply & Logistics Market Import-Export Trade Statistics |
7.1 India Clinical Trial Supply & Logistics Market Export to Major Countries |
7.2 India Clinical Trial Supply & Logistics Market Imports from Major Countries |
8 India Clinical Trial Supply & Logistics Market Key Performance Indicators |
8.1 Percentage increase in the number of clinical trial sites and facilities in India |
8.2 Average time taken for regulatory approvals for clinical trials |
8.3 Percentage of successful on-time delivery of clinical trial supplies |
8.4 Rate of adoption of digital technologies and automation in clinical trial logistics |
8.5 Number of partnerships and collaborations between research institutions and logistics providers in the clinical trial supply chain |
9 India Clinical Trial Supply & Logistics Market - Opportunity Assessment |
9.1 India Clinical Trial Supply & Logistics Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 India Clinical Trial Supply & Logistics Market Opportunity Assessment, By Phase, 2021 & 2031F |
9.3 India Clinical Trial Supply & Logistics Market Opportunity Assessment, By Therapeutic, 2021 & 2031F |
9.4 India Clinical Trial Supply & Logistics Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 India Clinical Trial Supply & Logistics Market - Competitive Landscape |
10.1 India Clinical Trial Supply & Logistics Market Revenue Share, By Companies, 2024 |
10.2 India Clinical Trial Supply & Logistics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here